Table 5.
Association of number of anti-GP2 and/or ASCA antibodies in one sample with disease characteristics in CD:pvalues for elevated (bold) or diminished (italic) prevalence of samples with differing numbers of anti-GP2 and/or ASCA in 169 CD patients detected by ELISAs with a cut-off of 20 U/ml
| |
Number of antibodies detected by ASCA and anti-GP2 ELISA |
|||
|---|---|---|---|---|
| at least one | at least two | at least three | Four | |
| L1 |
|
|
|
|
| L2 |
<0.001 |
<0.05 |
<0.03 |
|
| L3 |
<0.001 |
|
<0.04 |
|
| L4 |
|
|
|
|
| B1 |
|
|
|
|
| B2 |
<0.04 |
|
|
|
| B3 |
|
|
|
|
| B1p |
|
|
|
|
| B2p |
|
|
|
|
| B3p |
|
|
|
|
| A1 |
<0.006 |
<0.007 |
<0.03 |
<0.003 |
| A2 |
|
|
|
|
| A3 | ||||